Story
Riboflavin
Last updated
In one pass Riboflavin (vitamin B2) does relay work for the body's power supply.
Educational content, not medical advice — consult a clinician.
Story path
Chapter 1
Two electron-carrying parts
Riboflavin (vitamin B2) does relay work for the body's power supply. It is turned into two small parts that catch electrons and hand them on inside mitochondria, the small energy factories in each cell. Sugar and fat both pass through this step on their way to becoming usable energy.
The two parts are FMN (flavin mononucleotide) and FAD (flavin adenine dinucleotide). FMN sits on complex I, the first station of the respiratory chain. FAD is used more widely: complex II, the first step of breaking down fatty acids, and several amino-acid pathways all depend on it.
They behave like a tiny rechargeable battery. Catching electrons charges them (they become FADH₂ and FMNH₂); handing the electrons on discharges them (back to FAD and FMN). So B2 does not supply energy itself. Its job is to keep the electrons moving down the line.
The two parts are FMN (flavin mononucleotide) and FAD (flavin adenine dinucleotide). FMN sits on complex I, the first station of the respiratory chain. FAD is used more widely: complex II, the first step of breaking down fatty acids, and several amino-acid pathways all depend on it.
They behave like a tiny rechargeable battery. Catching electrons charges them (they become FADH₂ and FMNH₂); handing the electrons on discharges them (back to FAD and FMN). So B2 does not supply energy itself. Its job is to keep the electrons moving down the line.
Mechanism · Why urine turns bright yellow
After a multivitamin that contains B2, urine often turns bright yellow. That is riboflavin's own color: its name comes from the Latin flavus (yellow), and it is a natural yellow pigment.Whatever riboflavin the body cannot use right away is filtered by the kidneys into urine. So bright yellow urine shows that the vitamin was absorbed into the blood and is being cleared normally by the kidneys, not that it "wasn't absorbed". A brighter color roughly means more of it was beyond what you needed at that moment. The reverse tells you nothing: a supplement with little B2, or plenty of water, can leave no visible color at all. Some ads promise "our product won't turn your urine yellow". Usually that only means the product contains little B2, not that it is absorbed better.
Riboflavin also fluoresces: under ultraviolet light it glows yellow-green, the same kind of effect a banknote lamp uses to light up security ink. Clinical studies use this as a check on whether people took their pills (an adherence marker). A small amount of riboflavin is packed with the study drug, and later the urine is checked under UV light for the glow.
Dark urine first thing in the morning usually just means you drank nothing overnight and the urine is concentrated. It has nothing to do with B2.
Two kinds of urine color have nothing to do with B2 and need attention: tea-colored, cola-colored or dark brown, and red or bloody. They can come from muscle breakdown (rhabdomyolysis), liver problems or bleeding in the urinary tract. If your urine looks like this, especially with severe muscle pain and weakness, or with yellowing of the skin and the whites of the eyes, see a doctor promptly.
Chapter 2
How electrons become energy
At complex II, FADH₂ hands its electrons into the respiratory chain. The electrons pass down the chain, drive a set of proton pumps, and are finally turned into , the cell's energy currency. By the textbook count, each FADH₂ is worth about 1.5 ATP. FMN works at complex I: it takes electrons delivered by , another electron carrier, and passes them to a string of iron-sulfur (Fe-S) clusters that carry them onward.
So B2 does not make you feel wired. It simply keeps the electron current flowing. When you have enough, you never notice it. When you are short, the mechanism predicts that the tissues with the heaviest electron traffic and the fastest metabolism should suffer first.
So B2 does not make you feel wired. It simply keeps the electron current flowing. When you have enough, you never notice it. When you are short, the mechanism predicts that the tissues with the heaviest electron traffic and the fastest metabolism should suffer first.
Mechanism · Why light breaks down riboflavin
B2 is one of the few water-soluble vitamins that is highly sensitive to light. Visible and ultraviolet light break riboflavin down into lumiflavin and lumichrome, and neither product has any vitamin activity. In a clear glass bottle in strong direct light, more than 50% can be lost within 2-4 hours.That settles a few storage questions:
Milk keeps its B2 better in an opaque carton, a dark bottle or a stainless-steel can than in clear glass.Vitamin supplements are better kept in amber glass or opaque bottles.Fortified cereals belong in opaque packaging.
The same thing happens in hospitals. Newborn jaundice is treated with blue light at a wavelength of about 460 nm, which breaks down bilirubin in the skin. The same light also breaks down riboflavin in the baby's blood and tissues. Long phototherapy can use up B2, but treatment is usually short and breast milk supplies B2, so there is usually no visible consequence.
Eye doctors turned this property into a treatment. In keratoconus, the cornea thins and bulges forward. In corneal cross-linking (CXL), riboflavin drops are placed on the cornea and it is then exposed to ultraviolet A light, commonly for about 30 minutes. Riboflavin absorbs the UV light and produces reactive oxygen, which adds extra links (cross-links) between the collagen fibers of the cornea. The cornea stiffens, and the disease progresses more slowly. Over the past ten to fifteen years it has become a routine way to slow keratoconus.
Chapter 3
The B-vitamin enabler
B2 has a quieter job as well: it helps the other B vitamins. Several of them need FAD or FMN, both made from B2, at some step on the way to their working form:
The last oxidation step that turns vitamin B6 into its active form, pyridoxal phosphate (PLP), is done by an enzyme that works with FMN.In folate metabolism, the enzyme reshapes folate into the form that can give away a methyl group, and its cofactor is FAD.The body can make a little niacin from tryptophan, and the kynurenine hydroxylation step on that route also uses FAD.
So the B vitamins are not separate switches, each running its own job. They are a web that supplies one another. When B2 is short, some of the B6 and folate a person eats may go unused, even if intake looks fine.
The last oxidation step that turns vitamin B6 into its active form, pyridoxal phosphate (PLP), is done by an enzyme that works with FMN.In folate metabolism, the enzyme reshapes folate into the form that can give away a methyl group, and its cofactor is FAD.The body can make a little niacin from tryptophan, and the kynurenine hydroxylation step on that route also uses FAD.
So the B vitamins are not separate switches, each running its own job. They are a web that supplies one another. When B2 is short, some of the B6 and folate a person eats may go unused, even if intake looks fine.
Clinical · MTHFR genotype meets riboflavin
The C677T variant of the gene and a person's B2 status interact in a way that is little known but clinically meaningful.Start with the mechanism. The MTHFR enzyme converts 5,10-methylenetetrahydrofolate into 5-methyltetrahydrofolate, the form of folate that can hand a methyl group on, and it needs FAD in hand to do it. The C677T variant makes the enzyme hold FAD more loosely, so when FAD is scarce, the variant enzyme loses more of its activity. The result: people who are TT homozygous (the variant on both chromosomes) and also low in B2 have much lower MTHFR activity than TT people with enough B2, or than people without the variant who are low in B2. Same genes, different nutrition, different outcome.
Then the evidence. A research team in Northern Ireland ran several randomized trials in people with hypertension who had been genotyped beforehand, and the McNulty 2017 review pulls the results together. In TT homozygotes, 1.6 mg of riboflavin a day for 16 weeks lowered systolic blood pressure by 6-13 mmHg more than placebo, independent of the blood-pressure drugs they were taking. In people with the CT or CC genotype, riboflavin had no blood-pressure effect. An earlier study from the same team (McNulty 2006) found that riboflavin lowered in TT homozygotes.
In practice: for someone who is TT homozygous and also has hypertension, a history of stroke or raised homocysteine, a small dose of B2 (1.6-5 mg a day) is a cheap option to discuss with a doctor. It is a real example of choosing who gets a nutrient by genotype.
But not every TT homozygote needs extra B2. "If you've tested MTHFR, you must take B2" is another direct-sales line: the evidence points only to the small group who are TT homozygous and have hypertension, and most of it comes from a single research team.
nih-ods-folate
Chapter 4
Deficiency signs
When B2 runs short, the earliest signs usually show up around the mouth, on the tongue and on the skin. The usual explanation is that these tissues renew themselves quickly and need a lot of electron traffic:
Angular stomatitis: cracks at the corners of the mouthCheilitis: dry, cracked, red lipsGlossitis: a smooth tongue that looks red to purplishDermatitis: red, flaking skin in the folds beside the nose and behind the earsIn severe cases, new blood vessels grow into the cornea and the eyes look red
None of these is specific. Low iron, low B6, low zinc and other shortfalls can look the same, so you cannot diagnose low B2 from the mirror. Treat them as a clue that the overall quality of the diet may have slipped.
Angular stomatitis: cracks at the corners of the mouthCheilitis: dry, cracked, red lipsGlossitis: a smooth tongue that looks red to purplishDermatitis: red, flaking skin in the folds beside the nose and behind the earsIn severe cases, new blood vessels grow into the cornea and the eyes look red
None of these is specific. Low iron, low B6, low zinc and other shortfalls can look the same, so you cannot diagnose low B2 from the mirror. Treat them as a clue that the overall quality of the diet may have slipped.
Clinical · Who is at risk of low riboflavin
Where diets are varied, low B2 is uncommon, but a few groups carry a real risk.Risks linked to how people eat:
Strict vegetarians who eat no dairy or eggs: dairy is the largest B2 source for many people, so without it intake can sit at the margin.People with lactose intolerance who drink no milk at all and eat no fortified foods.People who drink heavily over the long term: they eat less and absorb less.People on very low-energy diets, long-term dieting, or with anorexia nervosa.Older people who live alone and eat a monotonous diet.
Risks linked to illness and medicines:
An underactive thyroid (hypothyroidism): thyroid hormone helps convert riboflavin into FAD and FMN, and that step slows when the thyroid is underactive.Several rare inherited disorders that respond to high-dose riboflavin, such as riboflavin transporter deficiency (Brown-Vialetto-Van Laere syndrome) and ACAD9 deficiency: the transporter or enzyme affected depends on riboflavin.Tricyclic antidepressants and phenothiazines: reported to block the conversion of riboflavin into FAD.Some antimalarials (such as quinine and chloroquine): reported to have a similar effect.Newborn phototherapy: it can use up B2 in the short term, for the reason given in the chapter on why light breaks riboflavin down.
Needs rise a little in pregnancy and breastfeeding. The US Recommended Dietary Allowance () is 1.4 mg/day in pregnancy and 1.6 mg/day while breastfeeding, against 1.3 mg/day for adult men and a little less for adult women. The gap is small, and an ordinary diet usually covers it.
For lab testing, the most common measure of B2 status is the erythrocyte glutathione reductase activity coefficient (EGRAC). The enzyme depends on FAD, and a coefficient > 1.4 suggests deficiency. It is rarely ordered in clinics; most of the time doctors judge from the diet and, if needed, simply supplement.
As for supplements, 5-10 mg a day is already several times the RDA. No toxicity from riboflavin has been found, so no tolerable upper intake level () has been set. Migraine prevention uses a different order of magnitude: 400 mg a day for several months, covered in the chapter on high doses and migraine.
One rare disorder comes up often: trimethylaminuria, also called fish-odor syndrome. It is an inborn shortfall of the enzyme FMO3, which needs FAD to work. The main approach is to eat fewer choline-rich foods, and some people also try riboflavin supplements. It is a specific metabolic disease, not an ordinary body-odor problem.
Chapter 5
High doses and migraine prevention
Riboflavin has an unexpected use: preventing migraine. The dose is pharmacological, 400 mg a day, far above the recommended intake and far beyond anything you could get by eating more leafy greens.
The idea behind it is a hypothesis about energy. Some people with migraine show lower energy output from their mitochondria, and FAD and FMN, both made from riboflavin, are core parts of complexes I and II of the respiratory chain. A high dose might raise the brain's energy reserve, so that the cortex is less prone to a wave of suppressed activity that spreads outward (cortical spreading depression), which is thought to be linked to migraine attacks.
The evidence rests mainly on one double-blind randomized trial of 55 people. The result was good, but the sample was small, later trials have not agreed with it, and the mechanism has not been shown directly. Riboflavin is used only to cut the number of attacks; it does not relieve pain during an attack.
The idea behind it is a hypothesis about energy. Some people with migraine show lower energy output from their mitochondria, and FAD and FMN, both made from riboflavin, are core parts of complexes I and II of the respiratory chain. A high dose might raise the brain's energy reserve, so that the cortex is less prone to a wave of suppressed activity that spreads outward (cortical spreading depression), which is thought to be linked to migraine attacks.
The evidence rests mainly on one double-blind randomized trial of 55 people. The result was good, but the sample was small, later trials have not agreed with it, and the mechanism has not been shown directly. Riboflavin is used only to cut the number of attacks; it does not relieve pain during an attack.
Evidence · What the riboflavin trial measured
The riboflavin and migraine story starts with a hypothesis about energy.The hypothesis: researchers found lower mitochondrial energy output in some people with migraine, and FAD, made from riboflavin, is a core part of complexes I and II of the respiratory chain. On this reasoning, high-dose riboflavin might raise the mitochondrial energy reserve and make the cortex less sensitive to cortical spreading depression, a wave of suppressed nerve activity that spreads outward from one spot in the cortex. That step has not been measured directly in people.
The trial itself: Schoenen and colleagues published a randomized double-blind trial in Neurology in 1998. Fifty-five people with migraine took 400 mg of riboflavin or placebo every day for 3 months. In the intention-to-treat analysis, both attack frequency and headache days fell more on riboflavin than on placebo. The share of people whose headache days fell by at least half (the "responders") was 59% on riboflavin and 15% on placebo. The (NNT) was 2.3: for roughly every two to three people treated, one more person responded. NIH ODS summarizes the absolute effect as about 2 fewer attacks a month.
That 59% is the share of people who responded. It does not mean "everyone had 59% fewer headache days", which is how the abstract's figure is often misread.
Where it stands: 400 mg a day is far above the adult recommended intake (1.1-1.3 mg/day). It is a pharmacological dose, not "eat more foods with B2". The 2012 guideline from the American Academy of Neurology and the American Headache Society (AAN/AHS; Holland 2012) rates riboflavin as "probably effective, should be considered". Magnesium gets the same rating; coenzyme is one step lower, at "possibly effective".
Limits: the original trial had only 55 people, later trials have not agreed, and the mechanism is not fully understood. It is still one of the few uses of riboflavin backed by a randomized trial. Anyone who wants migraine prevention should discuss it with a doctor first and rule out reasons not to take a high dose before starting one.
holland-2012-aan-guideline-migraine
In practice · Using riboflavin to prevent migraine
Riboflavin has some randomized-trial evidence for migraine prevention (not for stopping an attack), and it is one of the rare cases where a nutrient dose reaches the range of a drug. The studies need to be read separately:Schoenen 1998 (Belgium, 55 people, randomized and double-blind): 400 mg a day for 3 months. Responders, whose headache days fell by at least half, were 59% on riboflavin versus 15% on placebo ( 2.3). NIH ODS summarizes the absolute effect as about 2 fewer attacks a month.Boehnke 2004: an open-label follow-up study, not a placebo-controlled trial. Headache days fell from about 4 a month to 2, and pain intensity did not change.Maizels 2004: in 49 adults, a three-part supplement (riboflavin 400 mg plus magnesium 300 mg plus feverfew) was compared with a control that itself contained 25 mg of riboflavin. On the main outcome, the share of people whose headaches halved, the result was 42% versus 44%: no difference. It was not a trial in children, and it was not a positive repeat of Schoenen.Randomized trials in children and teenagers have given mixed results. Do not carry the adult 400 mg-a-day plan straight over to a child.The AAN/AHS 2012 guideline (Holland 2012) rates riboflavin and magnesium "probably effective, should be considered" and coenzyme "possibly effective".
How the main kinds of migraine prevention compare:
| Type | Examples | Evidence |
|---|---|---|
| Prescription preventives | propranolol, topiramate; botulinum toxin injections, used only for chronic migraine; CGRP antibodies | several randomized trials; chosen with a neurologist |
| Nutrients | riboflavin 400 mg, magnesium 600 mg, coenzyme Q10 300 mg | small randomized trials; AAN/AHS: possibly to probably effective |
| Lifestyle | regular sleep, finding triggers, exercise | mainly observational studies and clinical experience |
| Herbs | feverfew | results vary by preparation; AAN/AHS rates only one extract (MIG-99) as probably effective |
How it is used:
Take 400 mg of riboflavin a day, at once or split, and give it at least 3 full months before judging whether it works.The most common change is bright yellow or orange urine. That is riboflavin's own color and a sign it is being absorbed, not a problem.Side effects are rare (in the Schoenen trial, one case each of diarrhea and frequent urination on riboflavin). That is its advantage over prescription preventives, which commonly affect thinking, weight or heart rate.It can be combined with magnesium and coenzyme Q10 (100-300 mg a day), but the three together have not been well tested, and 600 mg of magnesium a day is above the tolerable upper intake level () for supplemental magnesium. Try any of these for 3-6 months under a doctor's guidance.
When to be careful:
If you take methotrexate or a similar anti-folate drug, riboflavin may affect how it is handled; ask your doctor first.In pregnancy, there are too few data on high doses; amounts within the recommended intake are safe.If the pain suddenly changes or new symptoms appear, do not assume it is migraine. See a doctor promptly to rule out stroke or a problem inside the skull.
Riboflavin cannot relieve pain during an attack. It is a prevention tool for people whose attacks are frequent (≥ 4 a month) and already affecting daily life, used to reduce how often attacks come.
maizels-2004-riboflavin-migraineboehnke-2004-riboflavin-openholland-2012-aan-guideline-migraine
References · 6
- National Institutes of Health, Office of Dietary Supplements. (2022). Riboflavin — Fact Sheet for Health Professionals. ods.od.nih.gov/factsheets/Riboflavin-HealthProfessional
- Powers, H. J. (2003). Riboflavin (vitamin B-2) and health. The American Journal of Clinical Nutrition, 77(6), 1352–1360. 10.1093/ajcn/77.6.1352
- National Institutes of Health, Office of Dietary Supplements. (2022). Niacin — Fact Sheet for Health Professionals. ods.od.nih.gov/factsheets/Niacin-HealthProfessional
- National Institutes of Health, Office of Dietary Supplements. (2022). Vitamin B6 — Fact Sheet for Health Professionals. Fact sheet (updated June 16, 2023; Wayback snapshot 17 September 2026): plasma PLP is the most common status measure; PLP above 30 nmol/L has been the traditional adequacy indicator in adults, but the FNB used 20 nmol/L as the major indicator when it calculated the adult RDAs; the FNB halved the dose used in the underlying studies to set an adult UL of 100 mg/day (fact sheet). ods.od.nih.gov/factsheets/VitaminB6-HealthProfessional
- McNulty, H., Strain, J. J., Hughes, C. F., & Ward, M. (2017). Riboflavin, MTHFR genotype and blood pressure: a personalized approach to prevention and treatment of hypertension. Molecular Aspects of Medicine, 53, 2–9. Narrative review, not a trial. It summarises: the MTHFR 677C>T polymorphism raises hypertension risk by 24-87% and CVD by up to 40% in epidemiological studies; in hypertensive patients pre-screened for the polymorphism, riboflavin lowered systolic BP by 6-13 mmHg in 677TT homozygotes, independently of antihypertensive drugs. The abstract gives no riboflavin dose, no trial duration and no result for CT or CC genotypes (abstract, PMID 27720779). 10.1016/j.mam.2016.10.002
- Schoenen, J., Jacquy, J., & Lenaerts, M. (1998). Effectiveness of high-dose riboflavin in migraine prophylaxis: a randomized controlled trial. Neurology, 50(2), 466–470. 10.1212/WNL.50.2.466